Thursday, July 21, 2011
Amira Pharmaceuticals Acquired By Bristol-Myers Squibb
San Diego-based Amira Pharmaceuticals, a developer of small molecule pharmaceuticals for treating inflammatory and fibrotic diseases, has agreed to be acquired by Bristol-Myers Squibb, the firms said late Thursday. Bristol-Myers Squibb said it would pay $325M upfront, and up to $150M in milestone payments, for Amira. Amira Pharmaceuticals was venture backed by Avalon Ventures, Novo A/S,Prospect Venture Partners, and Versant Ventures. The firm had raised somewhere around $40M in venture capital funding.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More